Over $12M Bet On This Healthcare Stock? Check Out These 3 Penny Stocks Insiders Are Aggressively Buying
Portfolio Pulse from Lisa Levin
Insiders at Evelo Biosciences, Dalrada Financial Corporation, and Augusta Gold Corp. have recently made significant purchases of their companies' stocks. Noubar Afeyan, a 10% owner of Evelo Biosciences, acquired 5,411,255 shares at an average price of $2.31, costing around $12.5 million. Brian Bonar, CEO of Dalrada Financial, bought 79,550 shares at an average price of $0.14, spending around $11,510. Richard Warke, Executive Chairman of Augusta Gold, purchased 10,000 shares at an average price of $0.78, costing around $7,750.
July 14, 2023 | 11:30 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Richard Warke, Executive Chairman of Augusta Gold, purchased 10,000 shares at an average price of $0.78, costing around $7,750.
Insider buying is often a positive sign that those with the most insight into a company's operations see it as undervalued. This could lead to a short-term increase in stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Brian Bonar, CEO of Dalrada Financial, bought 79,550 shares at an average price of $0.14, spending around $11,510.
Insider buying is often a positive sign that those with the most insight into a company's operations see it as undervalued. This could lead to a short-term increase in stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Noubar Afeyan, a 10% owner of Evelo Biosciences, acquired 5,411,255 shares at an average price of $2.31, costing around $12.5 million.
Insider buying is often a positive sign that those with the most insight into a company's operations see it as undervalued. This could lead to a short-term increase in stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100